1. Home
  2. GEVO vs TMCI Comparison

GEVO vs TMCI Comparison

Compare GEVO & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GEVO
  • TMCI
  • Stock Information
  • Founded
  • GEVO 2005
  • TMCI 2014
  • Country
  • GEVO United States
  • TMCI United States
  • Employees
  • GEVO N/A
  • TMCI N/A
  • Industry
  • GEVO Major Chemicals
  • TMCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • GEVO Industrials
  • TMCI Health Care
  • Exchange
  • GEVO Nasdaq
  • TMCI Nasdaq
  • Market Cap
  • GEVO 418.4M
  • TMCI 463.7M
  • IPO Year
  • GEVO 2011
  • TMCI 2021
  • Fundamental
  • Price
  • GEVO $1.67
  • TMCI $7.17
  • Analyst Decision
  • GEVO Buy
  • TMCI Hold
  • Analyst Count
  • GEVO 2
  • TMCI 5
  • Target Price
  • GEVO $7.58
  • TMCI $8.60
  • AVG Volume (30 Days)
  • GEVO 9.5M
  • TMCI 412.2K
  • Earning Date
  • GEVO 11-06-2025
  • TMCI 11-04-2025
  • Dividend Yield
  • GEVO N/A
  • TMCI N/A
  • EPS Growth
  • GEVO N/A
  • TMCI N/A
  • EPS
  • GEVO N/A
  • TMCI N/A
  • Revenue
  • GEVO $80,187,000.00
  • TMCI $213,751,000.00
  • Revenue This Year
  • GEVO $909.99
  • TMCI $10.63
  • Revenue Next Year
  • GEVO $22.37
  • TMCI $9.44
  • P/E Ratio
  • GEVO N/A
  • TMCI N/A
  • Revenue Growth
  • GEVO 341.75
  • TMCI 7.67
  • 52 Week Low
  • GEVO $0.67
  • TMCI $4.54
  • 52 Week High
  • GEVO $3.39
  • TMCI $10.79
  • Technical
  • Relative Strength Index (RSI)
  • GEVO 53.71
  • TMCI 59.79
  • Support Level
  • GEVO $1.54
  • TMCI $6.96
  • Resistance Level
  • GEVO $1.80
  • TMCI $7.35
  • Average True Range (ATR)
  • GEVO 0.10
  • TMCI 0.32
  • MACD
  • GEVO -0.02
  • TMCI -0.05
  • Stochastic Oscillator
  • GEVO 40.62
  • TMCI 37.76

About GEVO Gevo Inc.

Gevo Inc is a renewable chemicals and biofuels company engaged in the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks. The operating segments are the Gevo segment, GevoFuels segment, and the GevoRNG segment. By its segments, it is involved in research and development activities related to the future production of SAF, commercial opportunities for other renewable hydrocarbon products and isobutanol, including the development of its biocatalysts, and the produces-pipeline quality methane gas captured from dairy cow manure. The company derives maximum revenue from the GevoRNG segment.

About TMCI Treace Medical Concepts Inc.

Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.

Share on Social Networks: